Eczema (Atopic Dermatitis) and Cosmetic Procedures: Eyelid Eczema, Staph, Eczema Herpeticum, Lasers, Peels, Retinoids, Dupilumab, and JAK Inhibitors

She is 34 and has a short list. She wants the crepey, slightly darkened skin under her eyes improved, she has read about under-eye filler and tear trough treatment, and she is curious whether a laser could even out the texture on her cheeks. On the intake form, under medical history, she writes "eczema since childhood, mostly under control." Asked to say more, she mentions that she started a biologic injection two years ago, that her eyelids still flare every winter, that she has had pink eye more often since starting the shot, and that she rubs her eyes "constantly, probably too much." She has also had cold sores since she was a teenager.

Every one of those details matters, and none of them is a reason to send her away. Eczema (atopic dermatitis) is the most common chronic inflammatory skin disease in the country. The National Eczema Association, drawing on national survey data, estimates that roughly 7 percent of American adults live with it, which means a busy cosmetic practice sees eczema patients every week. The problem is that eczema is so familiar it gets treated as background noise. It is not. Eczema and cosmetic procedures interact in specific, predictable ways: the skin barrier is weaker, the skin surface usually carries more Staphylococcus aureus, herpes viruses spread across damaged skin more easily, many common skin care and surgical products are irritants or allergens, and the newer drugs that control the disease each come with their own questions about surgery. This piece covers what eczema changes for injections, lasers, peels, eyelid surgery, and body procedures, and what a reasonable plan looks like.

Eczema and cosmetic procedures: what atopic skin brings into the room

The short answer: Atopic dermatitis is a chronic, relapsing disease of a leaky skin barrier and an overactive type 2 immune response, and for cosmetic purposes its three big implications are more bacteria on the skin, a higher risk of widespread herpes infection, and a lower threshold for irritation and allergy.

Atopic dermatitis usually begins in childhood, but a substantial share of patients carry it into adulthood, and some develop it for the first time as adults. It is part of what allergists call the atopic triad, along with asthma and allergic rhinitis (hay fever), and many patients have more than one. That matters for surgery in its own right, which is why the piece on asthma before cosmetic surgery is worth reading for anyone who wheezes as well as itches.

Three features of eczema matter most once a needle, laser, or scalpel is involved:

• A broken barrier. In many patients the outer layer of skin is structurally weak, sometimes because of inherited variants in the filaggrin gene, a protein that helps hold the skin barrier together. The skin loses water faster and lets irritants in more easily. Practically, that means retinoids, acids, alcohol-based toners, and some antiseptics sting and inflame skin that tolerates nothing extra.
• More staph. A meta-analysis published in the British Journal of Dermatology in 2016 found Staphylococcus aureus on roughly 70 percent of lesional skin in atopic dermatitis patients and on about 39 percent of their skin that looked normal, far more than in people without eczema. Many also carry it in the nose. That colonization is one reason eczema flares are linked to skin infections, and the reason some surgeons recommend staph decolonization before cosmetic surgery for eczema patients.
• A weak antiviral defense in the skin. The same immune pattern that drives eczema dampens the skin's local defenses against viruses. The most serious consequence is eczema herpeticum, a widespread herpes simplex infection across eczematous or freshly injured skin, discussed in detail below.

Then there is the itch. Eczema is defined by it, and scratching is not a habit patients can simply stop. Scratching damages the skin, spreads bacteria, and can reopen a healing incision. Any honest recovery plan for an eczema patient has to include a plan for the itch.

One more distinction before any procedure: not every red, scaly patch on an eczema patient is eczema. Allergic contact dermatitis, perioral dermatitis, rosacea, psoriasis, fungal infections, and occasionally skin cancers can look similar. A new or unusual rash should be diagnosed by a dermatologist before anyone treats the skin around it as cosmetic.

The eyelids and the face: eyelid eczema, rubbing, and blepharoplasty

The short answer: Eyelid and under-eye changes in eczema patients are often inflammation, rubbing, and pigment rather than true excess skin or fat, so they need a correct diagnosis before anyone recommends filler or blepharoplasty, and eyelid surgery should wait until the eyelid skin has been calm for a sustained period.

The face is where eczema and cosmetic goals meet most directly, and the eyelids are where they collide. Eyelid skin is the thinnest on the body, and chronic eczema there produces a recognizable set of changes: fine wrinkling, a doubled crease under the lower lid known as the Dennie-Morgan fold, darkening of the skin under the eyes (the "allergic shiner"), thickening from repeated rubbing, and thinning of the outer eyebrows from rubbing and scratching. Many of these look like aging. They are not the same thing, and they do not respond to the same treatments.

That is the first trap. A patient with chronic eyelid eczema who asks about crepey lids or dark circles may be offered blepharoplasty for sagging skin and under-eye bags or tear trough filler when the dominant problem is inflammation and pigment. Surgery removes skin. It does not remove eczema, and it will not lighten pigment caused by years of rubbing. Controlling the dermatitis first, often for several months, frequently changes how much "excess" skin there appears to be. Only then can a surgeon judge what is truly redundant.

The second trap is allergy. A large share of eyelid dermatitis in adults, with or without a history of eczema, is allergic contact dermatitis rather than atopic disease. The eyelids react to things the hands touch first: nail polish, hair dye, fragrances, preservatives in cosmetics and eye drops, and nickel. Patch testing by a dermatologist identifies the culprit. It is worth doing before surgery, because the same allergens can turn up in post-operative ointments, tapes, and skin care.

The third trap is the eye itself. Atopic patients have higher rates of several eye conditions that affect eyelid surgery:

• Keratoconus. A progressive thinning and bulging of the cornea, strongly associated with chronic eye rubbing and with atopy.
• Cataracts and retinal problems. Atopic dermatitis is associated with earlier cataracts, and chronic rubbing and hitting of the face have been linked to retinal detachment.
• Chronic eye surface inflammation. Atopic keratoconjunctivitis is a serious allergic eye disease that can scar the eye's surface.
• Steroid effects. Years of steroid creams on the eyelids, or steroid eye drops, raise the risk of glaucoma and cataracts.
• Drug-related conjunctivitis. Conjunctivitis and other eye surface problems are a known side effect of dupilumab and related drugs, discussed below.

None of these forbids blepharoplasty. All of them argue for an eye exam by an ophthalmologist before it, a careful dry eye assessment after eyelid surgery and before it, and a conservative approach to how much lower lid skin is removed. An eyelid that is chronically inflamed, rubbed, and tight is a setup for the complications described in the piece on lower lid retraction after blepharoplasty.

For injections on the face, the rules are simpler. Neurotoxins and hyaluronic acid filler are generally reasonable in an eczema patient whose skin is calm. The key is not to inject through or near an active patch. Inflamed, broken, staph-colonized skin is a poor entry point for a needle, and any infection after filler is more consequential than one after a neurotoxin because the filler can harbor bacteria and contribute to the delayed filler nodules that are hard to clear. Lip filler deserves a specific question about chapped, inflamed lips (eczematous cheilitis), which is common in atopic patients and should be treated first.

"Surgery removes skin. It does not remove eczema, and it will not lighten pigment caused by years of rubbing. Control the dermatitis first, then decide what is truly extra."

Lasers, peels, and microneedling: eczema herpeticum, staph, and the barrier

The short answer: Resurfacing procedures deliberately injure the skin barrier that eczema has already weakened, so they should be done only on skin that has been quiet for months, with antiviral prophylaxis for anyone with a cold sore history, a plan to treat bacterial infection early, and gentler settings than a surgeon might choose for unaffected skin.

Resurfacing treatments work by injuring skin in a controlled way and letting it heal. That is exactly the situation in which eczema is most likely to cause trouble, for three reasons.

Eczema herpeticum. Herpes simplex, the virus behind cold sores, can spread rapidly across eczematous skin or freshly resurfaced skin, producing clusters of punched-out erosions, fever, and sometimes infection of the eye. This is eczema herpeticum (also called Kaposi varicelliform eruption), and it is a dermatologic emergency that needs prompt antiviral treatment and, if it involves the area around the eyes, an urgent eye examination. Cosmetic procedures can trigger herpes reactivation in anyone with a history of cold sores, as described in the piece on HSV reactivation after cosmetic procedures. In an eczema patient the stakes are higher because the virus has more vulnerable skin to spread across. For ablative laser resurfacing, medium and deep peels, and extensive facial microneedling, oral antiviral prophylaxis, typically valacyclovir started before the procedure and continued until the skin has re-covered, is standard practice for anyone with a cold sore history. Some surgeons give it to every resurfacing patient regardless of history, and for an eczema patient that is a reasonable default.

Bacterial infection. Resurfaced skin is an open wound for several days. Skin that already carries more staph is more likely to be infected. Signs worth calling about are crusting that turns yellow or honey-colored, increasing pain after the first few days, pustules, or spreading redness. Some practices prescribe decolonization in the week before an ablative procedure for eczema patients with frequent infections.

Irritation and pigment. Eczema patients often react to the very things a resurfacing protocol relies on: retinoids and hydroquinone during preparation, occlusive ointments containing lanolin or fragrance during healing, and topical antibiotics that are common contact allergens. Bacitracin and neomycin are among the well-known culprits. Prolonged redness and post-inflammatory hyperpigmentation are more likely after inflamed skin heals, especially in darker skin tones. That shifts the balance toward gentler choices. A non-ablative or fractional laser with longer intervals between sessions is usually a better first step than a fully ablative pass, and the piece comparing lasers and chemical peels explains the general tradeoffs. A deep phenol peel in a patient with active facial eczema is a poor bet.

A few specific points about common treatments:

• Retinoids. Prescription tretinoin and over-the-counter retinol are mainstays of skin preparation and maintenance, and they are among the most common reasons eczema patients flare their facial skin. If a retinoid is part of the plan, start at a low strength, a few nights a week, over a moisturizer, and stop it entirely during any flare. Many eczema patients simply cannot use one on the face, and that is fine.
• Microneedling. Hundreds of small punctures through a barrier that is already compromised, often followed by serums that were never meant to be driven into the skin. Microneedling over active eczema invites infection and allergic reactions. Over calm skin, with sterile technique and a plain post-treatment regimen, it is more reasonable.
• Laser hair removal and vascular lasers. These injure the skin less than resurfacing and are usually well tolerated once eczema is controlled, though a flare in the treated area should be allowed to settle before the next session.
• Chemical peels. Superficial peels can sting intensely on atopic skin. A test spot is a sensible precaution.

The general principle is that resurfacing should be scheduled for a season when the patient's eczema is reliably quiet. For many people with atopic dermatitis, winter is the worst season, so the late spring or early autumn may be the better window.

Dupilumab, JAK inhibitors, and steroid creams: the medication plan around surgery

The short answer: Most eczema treatments are continued through cosmetic procedures, but oral JAK inhibitors usually need a short pause and a clot risk discussion, steroid exposure needs to be accounted for, and every change should be made with the prescribing dermatologist rather than by the surgeon alone.

The eczema treatment landscape has changed more in the last decade than in the fifty years before it, and many patients now arrive on drugs their surgeon has not used in practice. Here is how the main categories generally relate to surgery. These are general patterns, not instructions. The final plan belongs to the dermatologist and surgeon together.

• Topical steroids. The backbone of eczema treatment. They are generally continued, but potent steroids should not be applied to incisions or freshly resurfaced skin, and long-term use on the face and eyelids thins skin and can affect the eyes. Patients using large amounts of potent steroid over large areas for long periods can absorb enough to suppress their own cortisol production, which matters for anesthesia. Some patients also describe a severe flare when long-term steroid creams are stopped, often called topical steroid withdrawal. Dermatologists continue to debate how to define it, but it is a reason not to stop steroid creams abruptly in the weeks before surgery without a plan.
• Topical calcineurin inhibitors. Tacrolimus ointment and pimecrolimus cream are often preferred on the eyelids and face because they do not thin skin. They can sting at first. They are usually paused on the treated area during healing and restarted once the skin has closed.
• Topical PDE4 and JAK creams. Crisaborole and topical ruxolitinib are newer options. Topical ruxolitinib carries the same boxed warning as the oral JAK class, though absorption from limited use is low. Stop applying them to the treatment area during healing.
• Dupilumab and related biologics. Dupilumab (Dupixent), approved for adults with atopic dermatitis in 2017, blocks signaling by interleukin-4 and interleukin-13. Tralokinumab and lebrikizumab target interleukin-13, and nemolizumab targets interleukin-31. These drugs are not broadly immunosuppressive in the way older drugs are, and there is no clear evidence that they raise surgical infection risk. Many dermatologists continue them through elective surgery, sometimes timing the operation midway between doses. Their most relevant side effects for cosmetic purposes are eye related: conjunctivitis and other eye surface inflammation occurred in roughly one in ten patients in the dupilumab trials and appear more often in real-world reports. That matters for eyelid surgery, and patients with dupilumab-related eye problems should have them addressed by an ophthalmologist before any blepharoplasty. Some patients on dupilumab also develop facial redness that can be mistaken for eczema or rosacea.
• Oral JAK inhibitors. Upadacitinib (Rinvoq) and abrocitinib (Cibinqo) are approved for moderate to severe atopic dermatitis and work quickly. They carry an FDA boxed warning, based largely on a large safety study of a related drug in older rheumatoid arthritis patients, for serious infections, death, cancer, major cardiovascular events, and blood clots. Two of those risks, infection and clots, are central to surgery. The 2022 perioperative guideline from the American College of Rheumatology and the American Association of Hip and Knee Surgeons, written for arthritis patients having joint replacement, recommends holding JAK inhibitors for at least three days before surgery and restarting once the wound is healing and there is no infection. Dermatologists often follow a similar approach for elective cosmetic surgery. The clot warning deserves particular attention before long operations and body procedures such as liposuction and tummy tucks, where a clot prevention plan should account for it.
• Older systemic drugs. Cyclosporine, methotrexate, mycophenolate, and azathioprine are still used. Decisions about them follow the same logic described in the piece on cosmetic surgery with autoimmune disease: weigh infection and healing risk against the risk of a flare, and coordinate with the prescriber.
• Oral steroids. Short courses of prednisone are still given for severe flares. A patient who has recently taken them, or takes them often, should tell the anesthesiologist, because recent steroid use can affect the body's stress response and wound healing. The piece on steroids for swelling after plastic surgery covers related issues.
• Sedating antihistamines. Diphenhydramine and hydroxyzine are often taken at night for itch. They add to the sedation of post-operative pain medication, and the combination deserves caution, especially in older patients and anyone with sleep apnea.

The worst outcome is a patient who stops everything to "be clean" for surgery and arrives with a full-body flare. A flare means more staph on the skin, more scratching, and more inflamed tissue near incisions. A stable, controlled patient is safer than an untreated one.

Incisions, tape, and the itch: body procedures and recovery with atopic skin

The short answer: For breast and body surgery, the main eczema issues are a skin prep and dressing plan that avoids irritants and allergens, attention to infection risk, a strategy for itch that keeps hands off incisions, and making sure that a persistent rash on one nipple is not something more serious than eczema.

Body procedures raise a different set of problems from facial ones. The incisions are longer, the dressings stay on longer, and the skin under compression garments and tape stays warm and damp, which can provoke eczema in people prone to it.

Skin prep and products. Surgical skin preparation with chlorhexidine or iodine, tapes and liquid adhesives, topical antibiotics, and fragranced healing creams are all potential irritants or allergens. Allergic contact dermatitis to surgical glue, a liquid adhesive often used to seal incisions, has been increasingly reported and can look alarming. The piece on adhesive and tape rash after cosmetic surgery covers that problem in detail. Patients with known allergies, or a history of reactions to tape or bandages, should say so in advance, and the piece on drug and chlorhexidine allergies explains how those are sorted out.

Infection risk. Several studies, mostly in orthopedic and cardiac surgery, have linked atopic dermatitis to higher rates of surgical site infection and wound complications, though not every study agrees and the risk appears concentrated in patients with active or severe disease. The practical lessons are consistent: operate on controlled skin, avoid incisions through active patches, consider decolonization for patients with frequent infections, and look early and carefully at any wound that is not following the expected course. A wound that opens after cosmetic surgery in an eczema patient should prompt a culture, not just a dressing change.

The itch. Healing incisions itch in everyone. In an eczema patient, the itch is louder, and sleep is when patients scratch without knowing it. Short, clean nails, cotton gloves at night for the first week or two, cool compresses, and a plain, unscented emollient on intact skin around (not on) the incision all help. The dermatologist can sometimes adjust treatment for the recovery period to keep itch under control. Scar care belongs on the same plan: silicone gels and sheets are generally well tolerated, but the products described in the piece on scar care after plastic surgery should be introduced one at a time so a reaction can be traced.

The nipples and breasts. Eczema of the nipple and areola is common in people with atopic dermatitis, usually affecting both sides and responding to treatment. Breast surgery that uses incisions around the areola should be scheduled when that skin is calm. There is one important exception: a scaly, itchy, or crusted rash on one nipple that does not clear with eczema treatment within a few weeks needs evaluation, and often a biopsy, to rule out Paget disease of the breast, a skin manifestation of underlying breast cancer. A plastic surgeon planning breast surgery who sees a one-sided nipple rash should stop and ask that question first.

Anesthesia and the atopic patient. Many eczema patients also have asthma, nasal allergies, or food allergies, and a few have had reactions to medications or latex. All of that belongs in the pre-operative interview. None of it is unusual for an experienced anesthesia team, but it needs to be known in advance.

For a patient deciding between surgeons, an eczema history is a good test of how carefully a practice works. A surgeon who asks about the specific medication, the eyelids, the cold sore history, and past reactions to tape is a surgeon who will notice other things. A second consultation is worth the time if the first one treated "eczema, controlled" as a line to skip.

The honest summary

Eczema does not disqualify anyone from cosmetic treatment, but it changes nearly every step of it. Atopic skin has a weaker barrier, carries more Staphylococcus aureus, reacts to more ingredients, and is more vulnerable to widespread herpes infection, so the central rule is simple: treat the skin when it is calm, not when it is flaring, and plan for the problems that are predictable. On the face, that means making sure under-eye darkening and crepey lids are not chronic eczema and rubbing before anyone sells filler or surgery for them, checking the eyes before eyelid surgery, and avoiding injections through active patches. For lasers, peels, and microneedling, it means choosing gentler options, scheduling for the patient's quietest season, and using antiviral prophylaxis for anyone with a cold sore history, because eczema herpeticum after resurfacing is a genuine emergency.

The medications need a deliberate plan rather than a reflexive pause. Biologics such as dupilumab are usually continued, with attention to the eye side effects that matter for blepharoplasty. Oral JAK inhibitors usually get a short pause before surgery and a careful look at clot risk before body procedures. Steroid creams should not be stopped abruptly without a plan. For body and breast surgery, the dressing, adhesive, and scar care products should be chosen with allergies in mind, and a rash on one nipple that does not clear deserves a biopsy rather than another tube of cream. The eczema patient who arrives with calm skin, a dermatologist who has reviewed the plan, an antiviral prescription if needed, and a surgeon who asked the right questions can expect to do well. The one who arrives in a flare, having stopped everything, needs the calendar moved, not the procedure rushed.